Crescendo Biologics

Crescendo Biologics

Crescendo Biologics

A rich internal pipeline of truly differentiated, multifunctional Humabody VH therapeutics with a focus on oncology
Raised
$70M
Follow us
Alexa global traffic share
Twitter followers
30 Apr 2018
$70,000,000
Venture capital (Series B)

Crescendo Biologics rakes in $70 mln Series B

PE HUB
+1